Related Experiment Videos
Clinical Prediction of Necrotizing Pneumonia in Children With Mycoplasma pneumoniae: A Model Based on Early Response
Jia Feng Zheng1, Meng Yao Zhang1, Han Quan Dong1
1Department of Pediatric Respiratory Medicine, Children's Hospital, Tianjin University/Tianjin Children's Hospital, Tianjin, China, hardinge.org.
Objective:
This study aimed to identify factors that predict progression to necrotizing pneumonia (NP) in children with Mycoplasma pneumoniae pneumonia (MPP) who fail to respond to initial therapy and to develop a predictive model to support early clinical decision-making.
Methods:
We retrospectively analyzed clinical and laboratory data of children with macrolide-unresponsive Mycoplasma pneumoniae pneumonia (MUMPP) admitted to Tianjin Children's Hospital from January 2021 to January 2025. MUMPP was defined as persistent fever (≥ 38.5°C, lasting ≥ 4 h/day) after ≥ 72 h of standardized intravenous macrolide therapy. Patients were classified into an observation group (n = 106, those who developed NP) and a control group (n = 130, those who did not). Independent predictors of NP were identified by multivariable logistic regression and incorporated into a nomogram. Model performance was evaluated using ROC analysis, calibration plots, and decision curve analysis.
Results:
In multivariable analysis, increased white blood cell (WBC) count (OR = 2.484, 95% CI: 1.406-4.613), longer fever duration (OR = 1.618, 95% CI: 1.217-2.193), pleural effusion (OR = 3.955, 95% CI: 1.664-10.00), and elevated C-reactive protein (CRP) (OR = 2.152, 95% CI: 1.547-3.074) were independently associated with NP among children with MPP after initial treatment failure. Calibration curves indicated close agreement between predicted and observed risks in both the derivation cohort (p = 0.588) and the validation cohort (p = 0.424). The model showed good discrimination, with an AUC of 0.848 (95% CI: 0.789-0.908) in the derivation cohort and 0.889 (95% CI: 0.815-0.963) in the validation cohort. Decision curve analysis suggested net clinical benefit across relevant threshold probabilities.
Conclusion:
Among children with MUMPP, higher WBC count, prolonged fever, pleural effusion, and higher CRP identify increased risk of NP.
Insights
Children with Mycoplasma pneumoniae pneumonia (MPP) unresponsive to treatment are at risk for necrotizing pneumonia (NP). Higher white blood cell count, prolonged fever, pleural effusion, and elevated C-reactive protein predict NP development.
Area of Science:
- Pediatric infectious diseases
- Respiratory medicine
- Clinical diagnostics
Background:
- Mycoplasma pneumoniae pneumonia (MPP) can lead to severe complications like necrotizing pneumonia (NP).
- Identifying children with MPP unresponsive to initial therapy who are at high risk for NP is crucial for timely intervention.
- Predictive factors for NP progression in macrolide-unresponsive MPP (MUMPP) require further elucidation.
Purpose of the Study:
- To identify predictors of necrotizing pneumonia (NP) in children with Mycoplasma pneumoniae pneumonia (MPP) who do not respond to initial treatment.
- To develop and validate a predictive model for early clinical decision-making in cases of treatment-resistant MPP.
Main Methods:
- Retrospective analysis of clinical and laboratory data from children with MUMPP.
- Classification of patients into observation (developed NP) and control (did not develop NP) groups.
- Multivariable logistic regression for predictor identification, nomogram development, and model validation using ROC analysis and calibration plots.
Main Results:
- Increased white blood cell (WBC) count, prolonged fever, pleural effusion, and elevated C-reactive protein (CRP) were independently associated with NP.
- The predictive model demonstrated good discrimination with an AUC of 0.848 in the derivation cohort and 0.889 in the validation cohort.
- Calibration plots showed close agreement between predicted and observed risks, indicating model reliability.
Conclusions:
- Higher WBC count, prolonged fever, presence of pleural effusion, and elevated CRP are key indicators of increased NP risk in children with MUMPP.
- The developed predictive model effectively identifies children at high risk for NP progression.
- This model can aid clinicians in making informed decisions for managing children with severe MPP.
Related Concept Videos
Atypical Pneumonia
Pneumonia III: Complications and Assessment